Medicinal product name Avamys
Pharmaceutical form Nasal spray, suspension
Strength 27.5 µg/spray 
Information from the MAH on shortages Not available
predicted availability date: May 12, 2024
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/07/434/003N1 Is available
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R01AD12 Nasal preparations

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(1789 containers)
predicted availability date: May 12, 2024
Tamro N1
(3,3 µg/120 dose)
Glass bottle 13.99  EU/1/07/434/003  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/07/434/003
Date of authorisation Jan 11, 2008
Marketing authorisation holder, country GlaxoSmithKline (Ireland) Limited, Ireland